(Q38014342)

27 August 2017

title

The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes (English)

1 reference

27 August 2017

0 references

0 references

Pedram Kazemian

1

1 reference

27 August 2017

Seyyed M R Kazemi-Bajestani

2

1 reference

27 August 2017

Aws Alherbish

3

1 reference

27 August 2017

Justin Steed

4

1 reference

27 August 2017

Gavin Y Oudit

5

1 reference

27 August 2017

language of work or name

1 reference

1 August 2012

1 reference

Cardiovascular Drugs and Therapy

27 August 2017

published in

1 reference

27 August 2017

volume

26

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

311-320

1 reference

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Hypertension prevention: from nutrients to (fortified) foods to dietary patterns. Focus on fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 polyunsaturated fatty acids and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

The science behind dietary omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

HFSA 2010 Comprehensive Heart Failure Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 fatty acids and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effects of supplementation with polyunsaturated fatty acids in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Obesity and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Insulin resistance and risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

n-3 fatty acids and cardiovascular events after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

The fish oil story remains fishy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish intake and risk of incident atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Blood levels of long-chain n-3 fatty acids and the risk of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Japan EPA Lipid Intervention Study (JELIS). Randomized clinical trial involving primary and secondary prevention of cardiovascular events with EPA in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effect of fish oil on arrhythmias and mortality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish intake and the risk of incident heart failure: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Cardiac-resynchronization therapy for mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

The effects of diet on inflammation: emphasis on the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

AMP-activated protein kinase signaling in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Effect of diet on adiponectin levels in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Adiponectin actions in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

Fish intake and acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6397-X

10.1007/S10557-012-6397-X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference